Ultrasonic diagnosis of venous thrombosis associated with peripherally inserted central venous catheters and the analysis of related factors

doi:10.3877/cma.j.issn.2095-655X.2017.03.010

Abstract

Abstract:

Objective

To investigate the diagnostic value of high frequency color Doppler ultrasonography in venous thrombosis associated with peripherally inserted central catheters(PICC), and to analyze the risk factors related to thrombosis.

Methods

A total of 83 patients were consecutively collected, who were suspected to be afflicted with venous thrombosis following PICC and underwent the examinaiton of color Doppler ultrasonography between June and December 2016, in Guangzhou First Municipal People′s Hospital.All the PICC-related veins were observed using GE Vivid E9 ultrasonic diagnostic equipment with high frequency probe.Clinical data of all cases (sex, age, underlying disease, duration and site of catheterization) and the detection of thrombus were retrospectively analysed.

Results

Thrombus was detected by high frequency color Doppler ultrasonography in PICC-related veins in 50 (60.2%) cases.The rate of thrombus detection (64.0%) within 2 weeks of venous catheterization was higher than that over 2 weeks (36.0%), but the difference was not statistically significant (χ²=0.74, P>0.05). Thrombus was found more often in patients over 50 years old with cerebrovascular accident and malignant tumor (64.0%), compared with that in other patients (36.0%, χ²=5.97, P<0.05).

Conclusions

High frequency color Doppler ultrasonography has important diagnostic value for PICC-related venous thrombosis.The thrombosis may occur more often within 2 weeks of PICC catheterization.Patients over 50 years old with cerebrovascular accident and malignant tumor are at higher risk of venous thrombosis following PICC, and are suggested to receive color Doppler ultrasonography timely with the aim of early diagnosis and treatment.

Key words: Peripherally inserted central venous catheters, Venous thrombosis, Ultrasonography, doppler, color

Zhilian Li, Yongsen Yu, Li Yang, Qi Xie. Ultrasonic diagnosis of venous thrombosis associated with peripherally inserted central venous catheters and the analysis of related factors[J]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(03): 179-182.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2017.03.010

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2017/V05/I03/179

Figures/Tables 3

References 23

[1]	朱屹华,赵勇. PICC在临床的应用及发展方向[J]. 吉林医学, 2013, 34(22): 4610.
[2]	Chopra V,Anand S,Hickner A, et al.Risk of venous thromboembolism associated with peripherally inserted central catheters：a systematic review and meta-analysis[J]. Lancet, 2013, 382(9889): 311-325.
[3]	彭星宇,方汉萍. PICC相关性静脉血栓危险因素及预防措施研究进展[J]. 齐鲁护理杂志, 2016, 22(3): 54-56.
[4]	王乔凤,岑敏琼,柯春连. 我科PICC置管术后并发症分析与对策[J]. 护理管理杂志, 2012, 12(3): 206, 216.
[5]	Klitfod L,Broholm R,Baekgaard N. Deep venous thrombosis of the upper extremity.A review[J]. Int Angiol, 2013, 32(5): 447-452.
[6]	Kato A,Takano H,Ichikawa A, et al.A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin[J]. Thromb Res, 2013, 131(2): 140-144.
[7]	Ong B,Gibbs H,Catchpole I, et al.Peripherally inserted central catheters and upper extremity deep vein thrombosis[J]. Australas Radiol, 2006, 50(5): 451-454.
[8]	Aw A,Carrier M,Koczerginski J, et al.Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients[J]. Thromb Res, 2012, 130(3): 323-326.
[9]	Ahn DH,Illum HB,Wang DH, et al.Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters：a retrospective analysis of risk factors[J]. J Oncol Pract, 2013, 9(1): 8-12.
[10]	Yi XL,Chen J,Li J, et al.Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients[J]. J Clin Nurs, 2014, 23(5-6): 837-843.
[11]	吴红娟,陈雪峰,张美英, 等. 肿瘤患者PICC置管主要并发症及其相关因素分析[J]. 中华护理杂志, 2008, 43(2): 134-135.
[12]	King MM,Rasnake MS,Rodriguez RG, et al.Peripherally inserted central venous catheter-associated thrombosis：retrospective analysis of clinical risk factors in adult patients[J]. South Med J, 2006, 99(10): 1073-1077.
[13]	Chemaly RF,de Parres JB,Rehm SJ, et al.Venous thrombosis associated with peripherally inserted central catheters：a retrospective analysis of the cleveland clinic experience[J]. Clin Infect Dis, 2002, 34(9): 1179-1183.
[14]	Nash EF,Helm EJ,Stephenson A, et al.Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis[J]. J Vasc Interv Radiol, 2009, 20(3): 347-351.
[15]	白玲,王勇,陈翠京, 等. PICC置管术后上肢静脉血栓113例诊治分析[J]. 人民军医, 2015, 58(9): 1087-1089.
[16]	张秀玲,柳建华. 彩超对肿瘤患者PICC术后上肢静脉血栓的诊断价值[J]. 临床医学工程, 2015, 22(2): 153-154, 159.
[17]	吴长福,孙培栋,毕振宇, 等. 上肢静脉入路PICC置管术应用解剖学研究[J]. 护理学报, 2011, 18(19): 8-11.
[18]	张洪臣.1500例老年人凝血指标分析[J]. 血栓与止血学, 2004, 10(1): 25.
[19]	郝轶,吐尔逊娜依·阿迪,穆玉明. 超声观察锁骨下静脉穿刺置管术后血栓形成因素[J]. 中国介入影像与治疗学, 2009, 6(2): 130-133.
[20]	李欣茹,孙建霞,张靓, 等. 超声诊断左颈内静脉血栓1例[J]. 中国医学影像技术, 2010, 26(8): 1514.
[21]	Kimata H,Yoshida A,Ishioka C, et al.Nerve growth factor specifically induces human IgG4 production[J]. Eur J Immunol, 1991, 21(1): 137-141.
[22]	刘聿秀,高玉芳. PICC相关上肢静脉血栓的研究进展[J]. 护理学报, 2010, 17(9): 14-17.
[23]	Fletcher JJ,Stetler W,Wilson TJ.The clinical significance of peripherally inserted central venous catheter-related deep vein thrombosis[J]. Neurocrit Care, 2011, 15(3): 454-460.

置管途径	置管时长		合计
置管途径	≤2周(n＝32)	>2周(n＝18)	合计
贵要静脉	19(38.0)	9(18.0)	28(56.0)
肱静脉	1(2.0)	4(8.0)	5(10.0)
颈内静脉	5(10.0)	1(2.0)	6(12.0)
锁骨下静脉	4(8.0)	3(6.0)	7(14.0)
股总静脉	3(6.0)	1(2.0)	4(8.0)
合计	32(64.0)	18(36.0)	50(100.0)

置管途径	置管时长		合计
置管途径	≤2周(n＝32)	>2周(n＝18)	合计
贵要静脉	19(38.0)	9(18.0)	28(56.0)
肱静脉	1(2.0)	4(8.0)	5(10.0)
颈内静脉	5(10.0)	1(2.0)	6(12.0)
锁骨下静脉	4(8.0)	3(6.0)	7(14.0)
股总静脉	3(6.0)	1(2.0)	4(8.0)
合计	32(64.0)	18(36.0)	50(100.0)

年龄	脑血管意外＋恶性肿瘤(n＝39)	其他疾病(n＝11)
≤50岁	7(14)	6(12)
>50岁	32(64)	5(10)
χ²值	5.97	?
P值	<0.05	?

年龄	脑血管意外＋恶性肿瘤(n＝39)	其他疾病(n＝11)
≤50岁	7(14)	6(12)
>50岁	32(64)	5(10)
χ²值	5.97	?
P值	<0.05	?

Please choose a citation manager

Content to export